PeptideDB

NSC95682 20035-41-0

NSC95682 20035-41-0

CAS No.: 20035-41-0

NSC95682 (6-Bromo-2-hydroxy-3-methoxybenzaldehyde), IRE-lα inhibitor compound 3-5, is a new and powerful IRE-1α inhibi
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

NSC95682 (6-Bromo-2-hydroxy-3-methoxybenzaldehyde), IRE-lα inhibitor compound 3-5, is a new and powerful IRE-1α inhibitor with an IC50 of 0.08 μM. It was taken from patent WO 2008154484 A1.



Physicochemical Properties


Molecular Formula C8H7BRO3
Molecular Weight 231.0434
Exact Mass 229.958
CAS # 20035-41-0
Related CAS # 20035-41-0
PubChem CID 262237
Appearance Light yellow to yellow solid
Density 1.653g/cm3
Boiling Point 282.1ºC at 760mmHg
Melting Point 102-105 °C(lit.)
Flash Point 124.4ºC
Vapour Pressure 0.00201mmHg at 25°C
Index of Refraction 1.622
LogP 1.975
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 2
Heavy Atom Count 12
Complexity 162
Defined Atom Stereocenter Count 0
SMILES

BrC1C([H])=C([H])C(=C(C=1C([H])=O)O[H])OC([H])([H])[H]

InChi Key JUPJZUTYDWXZAQ-UHFFFAOYSA-N
InChi Code

InChI=1S/C8H7BrO3/c1-12-7-3-2-6(9)5(4-10)8(7)11/h2-4,11H,1H3
Chemical Name

6-bromo-2-hydroxy-3-methoxybenzaldehyde
Synonyms

6-Bromo-2-hydroxy-3-methoxybenzaldehyde; NSC-95682; NSC 95682; NSC95682
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets IRE-1α (IC50 = 0.08 μM)
References

[1]. Ire-1a inhibitors. WO 2008154484 A1


Solubility Data


Solubility (In Vitro) DMSO: ~46~100 mg/mL (199.1~432.8 mM)
Ethanol: ~12 mg/mL (~51.9 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (10.82 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 4.3283 mL 21.6413 mL 43.2825 mL
5 mM 0.8657 mL 4.3283 mL 8.6565 mL
10 mM 0.4328 mL 2.1641 mL 4.3283 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.